TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
HRTX

Heron Therapeuti

Healthcare · Biotechnology

0.3157$ -0.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Heron Therapeuti (HRTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.2% of the shares are freely tradable; institutional investors hold 83.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 83.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 77.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 30.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 190Mio.

Largest Shareholders

Institutions

Institutions HRTX
Name Stake (%) Shares Change (%) Date
Rubric Capital Management LP 15.83 30,046,828 +0.0 03/31/2026
Clearline Capital LP 6.44 12,235,239 +0.0 03/31/2026
BlackRock Inc 5.32 10,106,422 -1.1 03/31/2026
Orbimed Advisors LLC 5.17 9,816,940 +0.0 03/31/2026
Velan Capital Investment Management LP 4.61 8,753,290 +0.0 06/30/2026
Vanguard Capital Management, LLC 4.11 7,810,329 +0.0 03/31/2026
Tejara Capital Ltd 3.43 6,510,795 +2.7 06/30/2026
TANG CAPITAL MANAGEMENT LLC 3.29 6,250,000 +0.0 03/31/2026
Palisade Capital Management LLc 3.23 6,140,639 -2.9 03/31/2026

Funds

Funds HRTX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.88 5,474,947 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings HRTX
Person Role Shares Value As of Type
Collard Craig A Chief Executive Officer 856,492 270,395 $ Jul 31, 2026 direct
Duarte Ira EVP, Chief Financial Officer 281,899 88,996 $ Jul 31, 2026 direct
Forbes William P EVP, Chief Development Officer 241,173 76,138 $ Jul 31, 2026 direct
Hensley Mark Earl Chief Operating Officer 170,901 53,953 $ Aug 6, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 6, 2026 Hensley Mark Earl Chief Operating Officer Other 8,888 0.50 4,444
Aug 6, 2026 Hensley Mark Earl Chief Operating Officer Other 31,250
Jul 31, 2026 Hensley Mark Earl Chief Operating Officer Other 11,769
Jul 31, 2026 Forbes William P EVP, Chief Development Officer Other 3,326 0.50 1,663
Jul 31, 2026 Forbes William P EVP, Chief Development Officer Other 11,694
Jul 31, 2026 Duarte Ira EVP, Chief Financial Officer Other 3,326 0.50 1,663
Jul 31, 2026 Duarte Ira EVP, Chief Financial Officer Other 11,694
Jul 31, 2026 Collard Craig A Chief Executive Officer Other 34,789
Jul 30, 2026 Forbes William P EVP, Chief Development Officer Other 3,348 0.50 1,674
Jul 30, 2026 Forbes William P EVP, Chief Development Officer Other 11,769
Jul 30, 2026 Duarte Ira EVP, Chief Financial Officer Other 3,850 0.50 1,925
Jul 30, 2026 Duarte Ira EVP, Chief Financial Officer Other 13,535
Jul 30, 2026 Collard Craig A Chief Executive Officer Other 50,021
Jul 19, 2026 Collard Craig A Chief Executive Officer Other 13,797
Jul 19, 2026 Forbes William P EVP, Chief Development Officer Other 1,101 0.47 517
Jul 19, 2026 Forbes William P EVP, Chief Development Officer Other 3,874
Jul 19, 2026 Duarte Ira EVP, Chief Financial Officer Other 1,101 0.47 517
Jul 19, 2026 Duarte Ira EVP, Chief Financial Officer Other 3,874

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?